Artigo
Acesso aberto
Revisado por pares
A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease
2011; Springer Nature; Volume: 70; Issue: 2 Linguagem: Inglês
10.1203/pdr.0b013e318220a553
ISSN1530-0447
AutoresTimothy F. Feltes, Henry M. Sondheimer, Robert Tulloh, Brian Harris, Kathryn Jensen, Genevieve A. Losonsky, M. Pamela Griffin,
Tópico(s)Parvovirus B19 Infection Studies
Referência(s)